Mini-trampoline Intervention vs. Nordic Walking: Balance, Fitness and Neuropsychological Effects
NCT ID: NCT02596152
Last Updated: 2020-11-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
54 participants
INTERVENTIONAL
2015-08-31
2017-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Mini-trampoline
participants allocated to this group will participate in a 12-week mini-trampoline group instructed training twice a week.
mini-trampoline
Intervention period lasts 12 weeks, training is group instructed, twice weekly. Training sessions are one hour each. The training intensity of the two interventional arms is comparable. The training progression is defined in advance.
Nordic Walking
participants allocated to this group will participate in a 12-week Nordic Walking group instructed training twice a week.
Nordic Walking
Intervention period lasts 12 weeks, training is group instructed, twice weekly. Training sessions are one hour each. The training intensity of the two interventional arms is comparable. The training progression is defined in advance.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
mini-trampoline
Intervention period lasts 12 weeks, training is group instructed, twice weekly. Training sessions are one hour each. The training intensity of the two interventional arms is comparable. The training progression is defined in advance.
Nordic Walking
Intervention period lasts 12 weeks, training is group instructed, twice weekly. Training sessions are one hour each. The training intensity of the two interventional arms is comparable. The training progression is defined in advance.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Body Mass Index ≥25 kg/m2
* ≤ 1h regular exercise/ physical activity per week
Exclusion Criteria
* inability to follow the procedures of the study (e.g. due to dementia)
* neurological disorders limiting balance or medications impairing balance
* hypertensive blood pressure not permitting exercise (\>180/100 mmHg)
* medication: beta-blocking agents which reduce cardiac adaption abilities to exercise
* known pregnancy with contraindications for exercise according to the guidelines of the American College of Obstetricians and Gynecologists
18 Years
55 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Arno Schmidt-Trucksäss
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Arno Schmidt-Trucksäss
Prof. Dr. Arno Schmidt-Trucksäss
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Basel, Department of Sport, Exercise and Health
Basel, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EKNZ 2015-231/232
Identifier Type: -
Identifier Source: org_study_id